HEADER OXIDOREDUCTASE/OXIDOREDUCATSE INHIBITOR 16-OCT-15 5EAE TITLE SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN TITLE 2 INHIBITOR R-DESTHIO-PROTHIOCONAZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: LANOSTEROL 14-ALPHA DEMETHYLASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: RDP IS THE SMALL MOLECULE R-DESTHIO-PROTHIOCONAZOLE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 307796; SOURCE 5 STRAIN: YJM789; SOURCE 6 GENE: ERG11, SCY_2394; SOURCE 7 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4932 KEYWDS CYP51, R-DESTHIO-PROTHIOCONAZOLE, OXIDOREDUCTASE-OXIDOREDUCTASE KEYWDS 2 INHIBITOR COMPLEX, OXIDOREDUCTASE-OXIDOREDUCATSE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.D.A.TYNDALL,M.SABHERWAL,A.A.SAGATOVA,M.V.KENIYA,R.K.WILSON, AUTHOR 2 M.V.WOODS,B.C.MONK REVDAT 3 27-SEP-23 5EAE 1 REMARK REVDAT 2 01-FEB-17 5EAE 1 JRNL REVDAT 1 10-FEB-16 5EAE 0 JRNL AUTH J.D.TYNDALL,M.SABHERWAL,A.A.SAGATOVA,M.V.KENIYA,J.NEGRONI, JRNL AUTH 2 R.K.WILSON,M.A.WOODS,K.TIETJEN,B.C.MONK JRNL TITL STRUCTURAL AND FUNCTIONAL ELUCIDATION OF YEAST LANOSTEROL 14 JRNL TITL 2 ALPHA-DEMETHYLASE IN COMPLEX WITH AGROCHEMICAL ANTIFUNGALS. JRNL REF PLOS ONE V. 11 67485 2016 JRNL REFN ESSN 1932-6203 JRNL PMID 27907120 JRNL DOI 10.1371/JOURNAL.PONE.0167485 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.A.SAGATOVA,M.V.KENIYA,R.K.WILSON,B.C.MONK,J.D.TYNDALL REMARK 1 TITL STRUCTURAL INSIGHTS INTO BINDING OF THE ANTIFUNGAL DRUG REMARK 1 TITL 2 FLUCONAZOLE TO SACCHAROMYCES CEREVISIAE LANOSTEROL REMARK 1 TITL 3 14ALPHA-DEMETHYLASE. REMARK 1 REF ANTIMICROB. AGENTS V. 59 4982 2015 REMARK 1 REF 2 CHEMOTHER. REMARK 1 REFN ESSN 1098-6596 REMARK 1 PMID 26055382 REMARK 1 DOI 10.1128/AAC.00925-15 REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.92 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 48230 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 2449 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.9291 - 6.5464 0.97 2925 143 0.1866 0.1921 REMARK 3 2 6.5464 - 5.2000 0.97 2885 173 0.1903 0.2341 REMARK 3 3 5.2000 - 4.5438 0.99 3011 144 0.1599 0.1675 REMARK 3 4 4.5438 - 4.1289 0.99 2992 169 0.1630 0.1846 REMARK 3 5 4.1289 - 3.8332 0.99 2984 181 0.1689 0.2403 REMARK 3 6 3.8332 - 3.6074 1.00 2992 175 0.1750 0.2203 REMARK 3 7 3.6074 - 3.4268 1.00 2995 145 0.1861 0.2037 REMARK 3 8 3.4268 - 3.2777 0.99 3009 161 0.1873 0.2744 REMARK 3 9 3.2777 - 3.1516 1.00 2963 167 0.2063 0.1933 REMARK 3 10 3.1516 - 3.0429 0.99 2961 161 0.1938 0.2341 REMARK 3 11 3.0429 - 2.9478 1.00 3007 179 0.1937 0.2554 REMARK 3 12 2.9478 - 2.8636 0.99 2991 172 0.1907 0.2211 REMARK 3 13 2.8636 - 2.7882 0.99 2971 140 0.1984 0.2242 REMARK 3 14 2.7882 - 2.7202 1.00 3030 150 0.2021 0.2337 REMARK 3 15 2.7202 - 2.6584 0.99 2990 174 0.2049 0.2604 REMARK 3 16 2.6584 - 2.6018 1.00 2969 110 0.2125 0.2516 REMARK 3 17 2.6018 - 2.5498 0.99 3051 163 0.2173 0.2369 REMARK 3 18 2.5498 - 2.5017 0.99 2967 161 0.2250 0.2399 REMARK 3 19 2.5017 - 2.4570 0.99 2966 153 0.2256 0.2919 REMARK 3 20 2.4570 - 2.4153 1.00 3003 165 0.2380 0.2501 REMARK 3 21 2.4153 - 2.3764 0.98 3029 122 0.2542 0.3034 REMARK 3 22 2.3764 - 2.3398 1.00 2998 148 0.2568 0.3061 REMARK 3 23 2.3398 - 2.3054 0.98 2905 176 0.2632 0.3413 REMARK 3 24 2.3054 - 2.2730 0.99 3043 153 0.2764 0.3281 REMARK 3 25 2.2730 - 2.2422 0.99 2941 162 0.2859 0.2994 REMARK 3 26 2.2422 - 2.2131 0.99 2972 181 0.3022 0.3220 REMARK 3 27 2.2131 - 2.1855 1.00 2971 165 0.3022 0.3419 REMARK 3 28 2.1855 - 2.1591 0.98 2969 169 0.3208 0.4130 REMARK 3 29 2.1591 - 2.1340 0.99 2932 156 0.3234 0.3567 REMARK 3 30 2.1340 - 2.1101 0.99 2993 164 0.3357 0.3214 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.42 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4472 REMARK 3 ANGLE : 1.074 6076 REMARK 3 CHIRALITY : 0.042 642 REMARK 3 PLANARITY : 0.005 779 REMARK 3 DIHEDRAL : 14.137 1659 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5EAE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-OCT-15. REMARK 100 THE DEPOSITION ID IS D_1000213337. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.4-9.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.954 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48243 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.110 REMARK 200 RESOLUTION RANGE LOW (A) : 38.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.11 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.84900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6 REMARK 200 STARTING MODEL: 4LXJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 45% PEG 400, 0.1M GLYCINE, PH 9.45, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.84000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 LYS A 5 REMARK 465 SER A 6 REMARK 465 HIS A 536 REMARK 465 HIS A 537 REMARK 465 HIS A 538 REMARK 465 HIS A 539 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 489 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 65 -47.79 66.90 REMARK 500 LEU A 96 52.89 38.57 REMARK 500 ILE A 139 -92.63 56.88 REMARK 500 ASP A 141 53.12 -111.73 REMARK 500 CYS A 142 153.05 178.99 REMARK 500 PHE A 184 -80.16 -124.25 REMARK 500 GLN A 279 -143.33 -105.18 REMARK 500 ASN A 290 70.17 -158.15 REMARK 500 SER A 291 39.42 -149.50 REMARK 500 MET A 363 71.61 -115.21 REMARK 500 ASP A 434 55.04 -156.69 REMARK 500 THR A 511 47.00 -84.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 602 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 470 SG REMARK 620 2 HEM A 602 NA 95.3 REMARK 620 3 HEM A 602 NB 89.5 88.3 REMARK 620 4 HEM A 602 NC 86.8 177.8 92.3 REMARK 620 5 HEM A 602 ND 92.2 91.7 178.3 87.6 REMARK 620 6 5L8 A 601 N31 177.1 86.4 92.8 91.5 85.5 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5L8 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM A 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4WMZ RELATED DB: PDB REMARK 900 4WMZ IS A COMPLEX OF THE SAME PROTEIN COMPLEXED WITH FLUCONAZOLE REMARK 900 RELATED ID: 5EAD RELATED DB: PDB REMARK 900 RELATED ID: 5EAC RELATED DB: PDB REMARK 900 RELATED ID: 5EAB RELATED DB: PDB REMARK 900 RELATED ID: 5EAF RELATED DB: PDB REMARK 900 RELATED ID: 5EAG RELATED DB: PDB REMARK 900 RELATED ID: 5EAH RELATED DB: PDB DBREF 5EAE A 1 530 UNP A6ZSR0 A6ZSR0_YEAS7 1 530 SEQADV 5EAE GLY A 531 UNP A6ZSR0 EXPRESSION TAG SEQADV 5EAE GLY A 532 UNP A6ZSR0 EXPRESSION TAG SEQADV 5EAE ARG A 533 UNP A6ZSR0 EXPRESSION TAG SEQADV 5EAE HIS A 534 UNP A6ZSR0 EXPRESSION TAG SEQADV 5EAE HIS A 535 UNP A6ZSR0 EXPRESSION TAG SEQADV 5EAE HIS A 536 UNP A6ZSR0 EXPRESSION TAG SEQADV 5EAE HIS A 537 UNP A6ZSR0 EXPRESSION TAG SEQADV 5EAE HIS A 538 UNP A6ZSR0 EXPRESSION TAG SEQADV 5EAE HIS A 539 UNP A6ZSR0 EXPRESSION TAG SEQRES 1 A 539 MET SER ALA THR LYS SER ILE VAL GLY GLU ALA LEU GLU SEQRES 2 A 539 TYR VAL ASN ILE GLY LEU SER HIS PHE LEU ALA LEU PRO SEQRES 3 A 539 LEU ALA GLN ARG ILE SER LEU ILE ILE ILE ILE PRO PHE SEQRES 4 A 539 ILE TYR ASN ILE VAL TRP GLN LEU LEU TYR SER LEU ARG SEQRES 5 A 539 LYS ASP ARG PRO PRO LEU VAL PHE TYR TRP ILE PRO TRP SEQRES 6 A 539 VAL GLY SER ALA VAL VAL TYR GLY MET LYS PRO TYR GLU SEQRES 7 A 539 PHE PHE GLU GLU CYS GLN LYS LYS TYR GLY ASP ILE PHE SEQRES 8 A 539 SER PHE VAL LEU LEU GLY ARG VAL MET THR VAL TYR LEU SEQRES 9 A 539 GLY PRO LYS GLY HIS GLU PHE VAL PHE ASN ALA LYS LEU SEQRES 10 A 539 ALA ASP VAL SER ALA GLU ALA ALA TYR ALA HIS LEU THR SEQRES 11 A 539 THR PRO VAL PHE GLY LYS GLY VAL ILE TYR ASP CYS PRO SEQRES 12 A 539 ASN SER ARG LEU MET GLU GLN LYS LYS PHE VAL LYS GLY SEQRES 13 A 539 ALA LEU THR LYS GLU ALA PHE LYS SER TYR VAL PRO LEU SEQRES 14 A 539 ILE ALA GLU GLU VAL TYR LYS TYR PHE ARG ASP SER LYS SEQRES 15 A 539 ASN PHE ARG LEU ASN GLU ARG THR THR GLY THR ILE ASP SEQRES 16 A 539 VAL MET VAL THR GLN PRO GLU MET THR ILE PHE THR ALA SEQRES 17 A 539 SER ARG SER LEU LEU GLY LYS GLU MET ARG ALA LYS LEU SEQRES 18 A 539 ASP THR ASP PHE ALA TYR LEU TYR SER ASP LEU ASP LYS SEQRES 19 A 539 GLY PHE THR PRO ILE ASN PHE VAL PHE PRO ASN LEU PRO SEQRES 20 A 539 LEU GLU HIS TYR ARG LYS ARG ASP HIS ALA GLN LYS ALA SEQRES 21 A 539 ILE SER GLY THR TYR MET SER LEU ILE LYS GLU ARG ARG SEQRES 22 A 539 LYS ASN ASN ASP ILE GLN ASP ARG ASP LEU ILE ASP SER SEQRES 23 A 539 LEU MET LYS ASN SER THR TYR LYS ASP GLY VAL LYS MET SEQRES 24 A 539 THR ASP GLN GLU ILE ALA ASN LEU LEU ILE GLY VAL LEU SEQRES 25 A 539 MET GLY GLY GLN HIS THR SER ALA ALA THR SER ALA TRP SEQRES 26 A 539 ILE LEU LEU HIS LEU ALA GLU ARG PRO ASP VAL GLN GLN SEQRES 27 A 539 GLU LEU TYR GLU GLU GLN MET ARG VAL LEU ASP GLY GLY SEQRES 28 A 539 LYS LYS GLU LEU THR TYR ASP LEU LEU GLN GLU MET PRO SEQRES 29 A 539 LEU LEU ASN GLN THR ILE LYS GLU THR LEU ARG MET HIS SEQRES 30 A 539 HIS PRO LEU HIS SER LEU PHE ARG LYS VAL MET LYS ASP SEQRES 31 A 539 MET HIS VAL PRO ASN THR SER TYR VAL ILE PRO ALA GLY SEQRES 32 A 539 TYR HIS VAL LEU VAL SER PRO GLY TYR THR HIS LEU ARG SEQRES 33 A 539 ASP GLU TYR PHE PRO ASN ALA HIS GLN PHE ASN ILE HIS SEQRES 34 A 539 ARG TRP ASN ASN ASP SER ALA SER SER TYR SER VAL GLY SEQRES 35 A 539 GLU GLU VAL ASP TYR GLY PHE GLY ALA ILE SER LYS GLY SEQRES 36 A 539 VAL SER SER PRO TYR LEU PRO PHE GLY GLY GLY ARG HIS SEQRES 37 A 539 ARG CYS ILE GLY GLU HIS PHE ALA TYR CYS GLN LEU GLY SEQRES 38 A 539 VAL LEU MET SER ILE PHE ILE ARG THR LEU LYS TRP HIS SEQRES 39 A 539 TYR PRO GLU GLY LYS THR VAL PRO PRO PRO ASP PHE THR SEQRES 40 A 539 SER MET VAL THR LEU PRO THR GLY PRO ALA LYS ILE ILE SEQRES 41 A 539 TRP GLU LYS ARG ASN PRO GLU GLN LYS ILE GLY GLY ARG SEQRES 42 A 539 HIS HIS HIS HIS HIS HIS HET 5L8 A 601 20 HET HEM A 602 43 HETNAM 5L8 (2~{R})-2-(1-CHLORANYLCYCLOPROPYL)-1-(2-CHLOROPHENYL)- HETNAM 2 5L8 3-(1,2,4-TRIAZOL-1-YL)PROPAN-2-OL HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN 5L8 R-DESTHIO-PROTHIOCONAZOLE HETSYN HEM HEME FORMUL 2 5L8 C14 H15 CL2 N3 O FORMUL 3 HEM C34 H32 FE N4 O4 FORMUL 4 HOH *171(H2 O) HELIX 1 AA1 VAL A 8 LEU A 23 1 16 HELIX 2 AA2 PRO A 26 SER A 50 1 25 HELIX 3 AA3 SER A 68 LYS A 75 1 8 HELIX 4 AA4 LYS A 75 GLY A 88 1 14 HELIX 5 AA5 GLY A 105 ASN A 114 1 10 HELIX 6 AA6 ALA A 122 GLY A 135 1 14 HELIX 7 AA7 PRO A 143 GLY A 156 1 14 HELIX 8 AA8 THR A 159 SER A 181 1 23 HELIX 9 AA9 VAL A 196 LEU A 213 1 18 HELIX 10 AB1 GLY A 214 LEU A 221 1 8 HELIX 11 AB2 ASP A 222 ASP A 224 5 3 HELIX 12 AB3 PHE A 225 GLY A 235 1 11 HELIX 13 AB4 PHE A 236 VAL A 242 5 7 HELIX 14 AB5 LEU A 248 ASN A 275 1 28 HELIX 15 AB6 ASP A 282 ASN A 290 1 9 HELIX 16 AB7 THR A 300 GLU A 332 1 33 HELIX 17 AB8 ARG A 333 LEU A 348 1 16 HELIX 18 AB9 THR A 356 GLN A 361 1 6 HELIX 19 AC1 MET A 363 HIS A 377 1 15 HELIX 20 AC2 SER A 409 HIS A 414 1 6 HELIX 21 AC3 ASN A 427 ASN A 432 5 6 HELIX 22 AC4 GLY A 465 ARG A 469 5 5 HELIX 23 AC5 GLY A 472 THR A 490 1 19 SHEET 1 AA1 5 ILE A 90 LEU A 95 0 SHEET 2 AA1 5 ARG A 98 TYR A 103 -1 O MET A 100 N PHE A 93 SHEET 3 AA1 5 HIS A 405 VAL A 408 1 O HIS A 405 N THR A 101 SHEET 4 AA1 5 LEU A 383 VAL A 387 -1 N LEU A 383 O VAL A 408 SHEET 5 AA1 5 VAL A 120 SER A 121 -1 N SER A 121 O LYS A 386 SHEET 1 AA2 3 THR A 191 ASP A 195 0 SHEET 2 AA2 3 LYS A 518 LYS A 523 -1 O ILE A 519 N ILE A 194 SHEET 3 AA2 3 LEU A 491 HIS A 494 -1 N HIS A 494 O ILE A 520 SHEET 1 AA3 2 MET A 391 HIS A 392 0 SHEET 2 AA3 2 VAL A 399 ILE A 400 -1 O ILE A 400 N MET A 391 SHEET 1 AA4 2 GLU A 444 ASP A 446 0 SHEET 2 AA4 2 ALA A 451 SER A 453 -1 O ILE A 452 N VAL A 445 LINK SG CYS A 470 FE HEM A 602 1555 1555 2.47 LINK N31 5L8 A 601 FE HEM A 602 1555 1555 2.27 CISPEP 1 GLY A 515 PRO A 516 0 -4.55 SITE 1 AC1 8 TYR A 126 PHE A 134 PHE A 236 GLY A 310 SITE 2 AC1 8 GLY A 314 LEU A 383 HEM A 602 HOH A 743 SITE 1 AC2 18 PHE A 113 TYR A 140 LEU A 147 LYS A 151 SITE 2 AC2 18 GLY A 315 THR A 318 PRO A 379 ARG A 385 SITE 3 AC2 18 PRO A 462 PHE A 463 GLY A 464 HIS A 468 SITE 4 AC2 18 CYS A 470 GLY A 472 ALA A 476 5L8 A 601 SITE 5 AC2 18 HOH A 743 HOH A 769 CRYST1 78.900 67.680 81.030 90.00 99.38 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012674 0.000000 0.002094 0.00000 SCALE2 0.000000 0.014775 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012508 0.00000